ArticleMaterials today. Bio2025

Corrigendum to "Oral olsalazine/ellagic acid/ZnCl2-modified in situ-forming hydrogels alleviates anxiety/depression-like symptoms and brain neural activity in colitis mice" [Mater Today Bio. 2025 Jul 8; 33:102058].

Tingting Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.